In recent years, attention has focused on three types of rifamycin-based short-course regimens for treatment of LTBI. These are (1) 3 to 4 months of rifampin, alone or in combination with INH; (2) 2 to 3 months of rifampin and pyrazinamide; and (3) 3 or fewer months of INH and rifapentine: